NorthWest Biotherapeutics Inc (NWBO)

[dpinvest]

The quote you provide is hardly a rule, and leaves lots of wiggle room. Exceptions should and would be made for treatments with exceptional safety, that are intended for particularly challenging illnesses where treatment choices are few, and the few available barely work and are overwhelmingly expensive, like for brain cancer which is still an expeditious death sentence upon diagnosis. DCVAX and other dendritic cell trials have repeatedly shown mind-boggling safety in the context of the average benefit provided. And consider that the only significant side effect is a two-day fever, implying that the main purpose of DCVAX, to boost and direct the immune system, is being achieved.